# Bevacizumab

## Avastin inj 100mg/4mL

| TAH Drug Code      | [IAVA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IAVA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 1. Metastatic Colorectal Cancer (mCRC) 2. Metastatic Breast Cancer (mBC) 3. Malignant Glioma (WHO Grade IV) - Glioblastoma 4. Advanced, Metastatic, or Recurrent Non-Squamous Non-Small Cell Lung Cancer (NSCLC) 5. Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer 6. Persistent, Recurrent, or Metastatic Cervical Cancer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | Infuse the initial dose over 90 minutes. The second infusion may be administered over 60 minutes if the initial infusion is well tolerated. The third and subsequent infusions may be administered over 30 minutes if the 60-minute infusion is well tolerated. Continue treatment until disease progression or unacceptable toxicity.  [Metastatic Colorectal Cancer (mCRC)]- 5 mg/kg every 2 weeks or 7.5 mg/kg every 3 weeks in combination withfluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy in patients who have progressed on a first-line Avastin-containing regimen.- 10 mg/kg every 2 weeks or 15 mg/kg every 2 weeks for Avastin-naive patients as second-line therapy.  [Metastatic Breast Cancer (mBC)] 10 mg/kg every 2 weeks  [Glioblastoma] 10 mg/kg every 2 weeks or 15 mg/kg every 3 weeks  [Non-Squamous Non-Small Cell Lung Cancer (NSCLC)] 15 mg/kg every 3 weeks  [Ovarian (epithelial), fallopian tube, or primary peritoneal cancer] - Stage III/IV disease following initial surgical resection: 15 mg/kg every 3 weeks (in combination with carboplatin and paclitaxel) for up to 6 cycles, followed by bevacizumab 15 mg/kg every 3 weeks (monotherapy), for a total of up to 22 cycles (=15 months) or until disease progression (whichever occurs earlier)- Platinum-sensitive recurrent: 15 mg/kg every 3 weeks (in combination with carboplatin and gemcitabine for 6-10 cycles or with carboplatin and paclitaxel for 6 to 8 cycles) then continue with bevacizumab (monotherapy) until disease progression or unacceptable toxicity- Platinum-resistant recurrent: 10 mg/kg every 2 weeks or 15 mg/kg every 3 weeks (in combination with paclitaxel, doxorubicin [liposomal], or topotecan)  [Cervical cancer] 15 mg/kg every 3 weeks (in combination with paclitaxel and either cisplatin or topotecan)                                                                                                                                                                                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to Chinese hamster ovary cell products or other recombinant human or humanised antibodies; untreated CNS metastases.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Adverse Effects    | Common: Hypertension, All Grades (19-42%), Hyperglycemia (26-31%), Hypomagnesemia (24-27%), Weight decreased (11-21%), Abdominal pain (12-61%), Constipation (13-40%), Diarrhea (19-39%), Indigestion (17-24%), Loss of appetite (34-43%), Nausea (58-72%), Stomatitis (15-33%), Taste sense altered (14-21%), Vomiting (33-52%), Hemorrhage, All Grades, Neutropenia, All Grades (Cervical cancer, 12%; ovarian cancer, 30.7%), Thrombocytopenia, All Grades (Colorectal carcinoma, 5%; ovarian cancer, 58%), Infectious disease (Cervical, ovarian, and non-small cell lung cancer, 10-13.6%; glioblastoma, 55%), Arthralgia (28-45%), Headache (22-49%), Proteinuria, All Grades (5-20%), Bleeding from nose (10-55%), Dyspnea (25-30%), Upper respiratory infection (40-47%), Fatigue (33-82%) Serious: Hypertension, Grades 3 to 5 (5-18%), Impaired wound healing (5-15%), Injection site extravasation, Necrotizing fasciitis, Wound dehiscence, Bleeding esophageal varices, Bleeding gastroesophageal varices, Gastrointestinal fistula (Up to 4.1%), Gastrointestinal hemorrhage (19-24%), Gastrointestinal perforation (0.3-3%), Tracheoesophageal fistula, Arterial thromboembolism (5%), Deep venous thrombosis (6-9%), Febrile neutropenia, Grades 3 to 5 (5-6.2%), Hemorrhage, Grade 3 or greater (0.4-7%), Leukopenia, Grade 3 or 4 (37-51%), Lymphocytopenia, Grade 3 or 4 (6%), Microangiopathic hemolytic anemia, Neutropenia, Grades 3 to 5 (Cervical cancer, 7.8%; colorectal and lung cancer, 21-27%), Thrombocytopenia, Grade 3 or 4 (21-40.1%), Thrombotic microangiopathy, Fistula of bile duct, Anaphylaxis, Hypersensitivity reaction, Intracranial hemorrhage (1.2-5%), Posterior reversible encephalopathy syndrome (<0.5%), Bladder fistula, Fistula from renal pelvis, Nephrotic syndrome (<1%), Proteinuria, Grades 3 to 5 (3-10%), Serum creatinine above reference range (13-16%), Non-menstrual vaginal bleeding (4%), Vaginal fistula finding, Bronchopleural fistula, Perforation of nasal septum, Pulmonary hemorrhage (4-31%), Pulmonary hypertension |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Moderate Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/bevacizumab-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

